Carregant...

Targeting HOX and PBX transcription factors in ovarian cancer

<p>Abstract</p> <p>Backgound</p> <p>Ovarian cancer still has a relatively poor prognosis due to the frequent occurrence of drug resistance, making the identification of new therapeutic targets an important goal. We have studied the role of <it>HOX </it>genes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Michael Agnieszka, Harrington Kevin J, Plowright Lynn, Morgan Richard, Pandha Hardev S
Format: Artigo
Idioma:Inglês
Publicat: BMC 2010-03-01
Col·lecció:BMC Cancer
Accés en línia:http://www.biomedcentral.com/1471-2407/10/89
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!